253 related articles for article (PubMed ID: 14640991)
41. Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man.
Schiffelers SL; Brouwer EM; Saris WH; van Baak MA
Metabolism; 1998 Dec; 47(12):1462-7. PubMed ID: 9867074
[TBL] [Abstract][Full Text] [Related]
42. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
[TBL] [Abstract][Full Text] [Related]
43. Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.
Vaag AA; Beck-Nielsen H
Acta Endocrinol (Copenh); 1992 Oct; 127(4):344-50. PubMed ID: 1449046
[TBL] [Abstract][Full Text] [Related]
44. Plasma free fatty acids and serum insulin in subjects feeding at 12-hour intervals; effects of methionyl growth hormone and of acipimox, an inhibitor of lipolysis.
Pontiroli AE; Lanzi R; Monzani M; Musatti L; Guglielmone C; Pozza G
J Endocrinol Invest; 1992 Feb; 15(2):85-91. PubMed ID: 1569294
[TBL] [Abstract][Full Text] [Related]
45. Effects of growth hormone and free fatty acids on insulin sensitivity in patients with type 1 diabetes.
Salgin B; Marcovecchio ML; Williams RM; Jackson SJ; Bluck LJ; Humphreys SM; Acerini CL; Dunger DB
J Clin Endocrinol Metab; 2009 Sep; 94(9):3297-305. PubMed ID: 19567515
[TBL] [Abstract][Full Text] [Related]
46. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
[TBL] [Abstract][Full Text] [Related]
47. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström R; Packard CJ; Caslake M; Bedford D; Stewart P; Yki-Järvinen H; Shepherd J; Taskinen MR
Diabetes; 1998 May; 47(5):779-87. PubMed ID: 9588450
[TBL] [Abstract][Full Text] [Related]
48. Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
Dullaart RP; Riemens SC; Meinardi JR; Wolffenbuttel BH; Sluiter WJ
Scand J Clin Lab Invest; 2005; 65(6):523-31. PubMed ID: 16179286
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of lipolysis in Type 2 diabetes normalizes glucose disposal without change in muscle glycogen synthesis rates.
Lim EL; Hollingsworth KG; Smith FE; Thelwall PE; Taylor R
Clin Sci (Lond); 2011 Aug; 121(4):169-77. PubMed ID: 21388348
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
Makimura H; Stanley TL; Suresh C; De Sousa-Coelho AL; Frontera WR; Syu S; Braun LR; Looby SE; Feldpausch MN; Torriani M; Lee H; Patti ME; Grinspoon SK
J Clin Endocrinol Metab; 2016 Mar; 101(3):1123-33. PubMed ID: 26691888
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
[TBL] [Abstract][Full Text] [Related]
52. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
53. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
Blachère JC; Pérusse F; Bukowiecki LJ
Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
[TBL] [Abstract][Full Text] [Related]
54. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
[TBL] [Abstract][Full Text] [Related]
55. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
[TBL] [Abstract][Full Text] [Related]
56. Acipimox enhances spontaneous growth hormone secretion in obese women.
Kok P; Buijs MM; Kok SW; Van Ierssel IH; Frölich M; Roelfsema F; Voshol PJ; Meinders AE; Pijl H
Am J Physiol Regul Integr Comp Physiol; 2004 Apr; 286(4):R693-8. PubMed ID: 14670810
[TBL] [Abstract][Full Text] [Related]
57. The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.
Nørrelund H; Nair KS; Nielsen S; Frystyk J; Ivarsen P; Jørgensen JO; Christiansen JS; Møller N
J Clin Endocrinol Metab; 2003 Sep; 88(9):4371-8. PubMed ID: 12970312
[TBL] [Abstract][Full Text] [Related]
58. Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
Gautier JF; Pirnay F; Jandrain B; Lacroix M; Mosora F; Scheen AJ; Cathelineau G; Lefèbvre PJ
Eur J Appl Physiol Occup Physiol; 1994; 68(5):406-12. PubMed ID: 8076620
[TBL] [Abstract][Full Text] [Related]
59. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
60. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
Hadigan C; Liebau J; Torriani M; Andersen R; Grinspoon S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4438-44. PubMed ID: 16940448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
